Lomitapide, relief pitcher for patients with homozygous familial hypercholesterolemia

被引：4
|
作者：
Kim, Sang-Hyun [1 ]
Baek, Sang Hong [2 ]
机构：
[1] Seoul Natl Univ, Seoul Boramae Hosp, Coll Med, Cardiol,Internal Med, Seoul, South Korea
[2] Catholic Univ Korea, Seoul St Marys Hosp, Internal Med, Cardiovasc Med, Seoul, South Korea
来源：
EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY | 2020年 / 27卷 / 02期
关键词：
EFFICACY;
D O I：
10.1177/2047487319881240
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：155 / 156
页数：2
相关论文
共 50 条
  • [21] LOWER: A REGISTRY EVALUATING LONG-TERM LOMITAPIDE USE IN PATIENTS WITH HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA
    Underberg, James
    Blom, Dirk
    Kastelein, John
    Larrey, Dominique
    Makris, Lukas
    Phillips, Helen
    Schwamlein, Charles
    CLINICAL CARDIOLOGY, 2015, 38 : 9 - 9
  • [22] Gradual dose Titration of Lomitapide may Prevent Therapeutic Delays in Patients with Homozygous Familial Hypercholesterolemia
    Harada-Shiba, Mariko
    Koezuka, Ryo
    Makino, Hisashi
    Ogura, Masatsune
    JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS, 2023, 30 (02) : 203 - 205
  • [23] LDL-C THERAPEUTIC TARGET ATTAINMENT IN PATIENTS WITH HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA TREATED WITH LOMITAPIDE
    Underberg, James
    Harada-Shiba, Mariko
    Hegele, Robert A.
    McCullough, Peter A.
    DiGioia, Kenneth
    Jurecka, Agnieszka
    Stefanutti, Claudia
    Blom, Dirk
    ATHEROSCLEROSIS SUPPLEMENTS, 2018, 32 : 153 - 154
  • [24] Lomitapide for the Management of Homozygous Familial Hypercholesterolemia (vol 15, pg 109, 2014)
    deGoma, Emil M.
    REVIEWS IN CARDIOVASCULAR MEDICINE, 2014, 15 (03) : 281 - 282
  • [25] Lomitapide-a Microsomal Triglyceride Transfer Protein Inhibitor for Homozygous Familial Hypercholesterolemia
    Stefanutti, Claudia
    CURRENT ATHEROSCLEROSIS REPORTS, 2020, 22 (08)
  • [26] Treating homozygous familial hypercholesterolemia in a real-world setting: Experiences with lomitapide
    van Lennep, Jeanine Roeters
    Averna, Maurizio
    Alonso, Rodrigo
    JOURNAL OF CLINICAL LIPIDOLOGY, 2015, 9 (04) : 607 - 617
  • [27] The effect of lomitapide on cardiovascular outcome measures in homozygous familial hypercholesterolemia: A modelling analysis
    Leipold, Robert
    Raal, Frederick
    Ishak, Jack
    Hovingh, Kees
    Phillips, Helen
    EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY, 2017, 24 (17) : 1843 - 1850
  • [28] Lomitapide for homozygous familial hypercholesterolaemia
    Raal, Frederick J.
    LANCET, 2013, 381 (9860): : 7 - 8
  • [29] Long-term effectiveness and safety of lomitapide in patients with homozygous familial hypercholesterolemia: an observational case series
    Suppressa, Patrizia
    Coppola, Chiara
    Cocco, Veronica
    O'Brien, Sallyann
    ORPHANET JOURNAL OF RARE DISEASES, 2024, 19 (01)
  • [30] Microsomal triglyceride transfer protein inhibitor (lomitapide) efficacy in the treatment of patients with homozygous familial hypercholesterolemia phenotype
    Fountas, E.
    Diakoumakou, O.
    Kolovou, V.
    Stratakis, S.
    Zacharis, E.
    Liberopoulos, E.
    Matsouka, F.
    Tsoutsinos, A.
    Mastorakou, I.
    Katsikas, T.
    Mavrogeni, S.
    Hatzigeorgiou, G.
    Kolovou, G.
    EUROPEAN HEART JOURNAL, 2019, 40 : 3258 - 3258
12345